Biomarkers for prostate cancer and methods using the same
US8518650B2 · kind B2 · utility
3Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2007 |
| Grant date | Aug 27, 2013 |
| Priority date | — |
| Expiry date | May 3, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/201666
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods for identifying and evaluating suites of biochemical and/or gene entities useful as biomarkers for early prediction of prostate cancer, disease grading, target identification/validation, and monitoring of drug efficacy are provided. Also provided are suites of small molecule entities as biomarkers for prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.